Israel, on the other hand, is gearing up for large scale serology tests in order to gauge the proportion of population which has developed antibodies against the novel coronavirus. Israel, whose aggressive response to the coronavirus has held its fatality rate to a fraction of those of the United States and other hard-hit nations, is readying a nationwide serological test of 100,000 citizens. Moshe Bar-Siman-Tov, director-general of Israel’s Health Ministry, said that if antibody tests show a sizable portion of the population has developed antibodies, that could mean Israel is on its way to “herd immunity” and would be well equipped to withstand further outbreaks. Meanwhile, studies have estimated the percentage of Israelis with antibodies range widely, from less than 1% to upward of 10%. … [Read more...] about In-Depth: Is Herd Immunity our best bet in the fight against coronavirus?
'Upside momentum in Nifty seen only above 9,200, bet on these 3 stocks for double-digit returns'Story in a chart: 'Cup & Handle' pattern in Motherson Sumi suggests buying opportunity'Expect markets to be volatile amid uncertain global sentiment; these 3 stocks can give double-digit returns' … [Read more...] about Story in a chart: Cup & Handle pattern suggests buying opportunity in D-Mart
Stock can form a double bottom price pattern on the daily chart if it defends its major support line, which should resolve on the upside after its brief consolidation. The momentum oscillator RSI is in positive territory and entering into a trending phase. The MACD too indicates good momentum-trend follow-through. We recommend buy ICICI Bank around Rs 280 with a stop loss of Rs 240 and a target price of Rs 340. … [Read more...] about ‘Upside momentum in Nifty seen only above 9,200, bet on these 3 stocks for double-digit returns’
"Markets have closed on a positive note, after a volatile day of trade, in anticipation of GDP data due out later today. Global cues also were negative, following heightened US-China diplomatic issues, which offset stimulus news and economies opening up," Vinod Nair- Head of Research at Geojit Financial Services said. … [Read more...] about Taking Stock: Volatile Friday! Nifty reclaims 9,500; Sensex rallies over 200 points
Currently, Intas has over 10,000 product registrations worldwide. In India, it has established leadership in key therapeutic segments like CNS, cardiovascular, diabetology, gastroenterology, urology and oncology. In terms of revenues, it registered a CAGR ( compounded annual growth rate) of 25.5 percent between 2012 and 2019 and clocked $1.88 billion in revenues as of March 2019, according to its website. … [Read more...] about Exclusive | PE firm ChrysCapital to buy out Capital International’s stake in Intas Pharmaceuticals